 component,
with variable responses regarding ranking of
discomfort and long-term risk of recurrence;
given that superï¬cial venous disease is a
chronic disease and a consensus is lacking
regarding patient preference, the
committee prioritized QoL at 5 years and
recurrence/need for reintervention over
short-term results

Possibly
important
uncertainty or
variability

What is the overall certainty of the
evidence of effects?

Moderate certainty for ven